Impaired activity of volume-sensitive Cl- channel is involved in cisplatin resistance of cancer cells

Journal of Cellular Physiology

Volumn 211, Issue 2, 2007, Pages 513-521

  Lee, Elbert L ^a   Shimizu, Takahiro ^a   Ise, Tomoko ^b,c   Numata, Tomohiro ^a   Kohno, Kimitoshi ^b   Okada, Yasunobu ^a  

^a NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CHLORIDE CHANNEL; CHLORIDE CHANNEL BLOCKING AGENT; CISPLATIN; HISTONE DEACETYLASE INHIBITOR; TRICHOSTATIN A;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CHLORIDE CURRENT; CONTROLLED STUDY; DRUG POTENTIATION; DRUG RESISTANCE; DRUG RESPONSE; DRUG SENSITIVITY; DRUG TREATMENT FAILURE; ENZYME REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA;

4,4'-DIISOTHIOCYANOSTILBENE-2,2'-DISULFONIC ACID; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL MEMBRANE; CELL SIZE; CELL SURVIVAL; CHLORIDE CHANNELS; CISPLATIN; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; ENZYME INHIBITORS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; ION CHANNEL GATING; MEMBRANE POTENTIALS; PHENOTYPE; PHLORETIN; TIME FACTORS;

EID: 34147208877     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20961     Document Type: Article

References (48)

1. - channel gene. J Physiol 545:207-216.
2. Bortner CD, Cidlowski JA. 2002. Apoptotic volume decrease and the incredible shrinking cell. Cell Death Differ 9:1307-1310.
3. Bortner CD, Cidlowski JA. 2004. The role of apoptotic volume decrease and ionic homeostasis in the activation and repression of apoptosis. Pflügers Arch 448:313-318.
4. Chap CC. 1996. Molecular basis of cis-diamminedichloroplatinum(II) resistance: A review. J Formos Med Assoc 95:893-900.
5. Chen ZS, Mutoh M, Sumizawa T, Furukawa T, Haraguchi M, Tani A, Saijo N, Kondo T, Akiyama S. 1998. An active efflux system for heavy metals in cisplatin-resistant human KB carcinoma cells. Exp Cell Res 240:312-320.
6. Chu G. 1994. Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. J Biol Chem 269:787-790.
7. Chuman Y, Chen ZS, Sumizawa T, Furukawa T, Haraguchi M, Takebayashi Y, Niwa K, Yamada K, Aikou T, Akiyama S. 1996. Characterization of the ATP-dependent LTC4 transporter in cisplatin-resistant human KB cells. Biochem Biophys Res Commun 226:158-165.
8. Davies AR, Belsey MJ, Kozlowski RZ. 2004. Volume-sensitive organic osmolyte/anion channels in cancer: Novel approaches to studying channel modulation employing proteomics technologies. Ann N Y Acad Sci 1028:38-55.
9. De Greef C, van der Heyden S, Viana F, Eggermont J, De Bruijn EA, Raeymaekers L, Droogmans G, Nilius B. 1995. Lack of correlation between mdr-1 expression and volume-activation of chloride-currents in rat colon cancer cells. Pflügers Arch 430:296-298.
10. Duan D, Winter C, Cowley S, Hume JR, Horowitz B. 1997. Molecular identification of a volume-regulated chloride channel. Nature 390:417-421.
11. Eastman A. 1990. Activation of programmed cell death by anticancer agents: Cisplatin as a model system. Cancer Cells 2:275-280.
12. Ehring GR, Osipchuk YV, Cahalan MD. 1994. Swelling-activated chloride channels in multidrug-sensitive and -resistant cells. J Gen Physiol 104:1129-1161.
13. - channels. Br J Pharmacol 133:1096-1106.
14. Fujii R, Mutoh M, Niwa K, Yamada K, Aikou T, Nakagawa M, Kuwano M, Akiyama S. 1994. Active efflux system for cisplatin in cisplatin-resistant human KB cells. Jpn J Cancer Res 85:426-433.
15. Gately DP, Howell SB. 1993. Cellular accumulation of the anticancer agent cisplatin: A review. Br J Cancer 67:1171-1176.
16. - channel in mouse ventricular cardiomyocytes. Cell Physiol Biochem 14:213-224.
17. Henderson C, Brancolini C. 2003. Apoptotic pathways activated by histone deacetylase inhibitors: Implications for the drug-resistant phenotype. Drug Resist Updat 6:247-256.
18. - channel in cisplatin-induced apoptosis in human epidermoid cancer cells. J Membr Biol 205:139-145.
19. Kartalou M, Essigmann JM. 2001. Mechanisms of resistance to cisplatin. Mutat Res 478:23-43.
20. Kim MS, Blake M, Baek JH, Kohlhagen G, Pommier Y, Carrier F. 2003. Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. Cancer Res 63:7291-7300.
21. - channel currents in cultured human epithelial cells. J Physiol 456:351-371.
22. Kunzelmann K. 2005. Ion channels and cancer. J Membr Biol 205:159-173.
23. Liang XJ, Shen DW, Garfield S, Gottesman MM. 2003. Mislocalization of membrane proteins associated with multidrug resistance in cisplatin-resistant cancer cell lines. Cancer Res 63:5909-5916.
24. - channels by dual mechanisms. Am J Physiol 275:C343-C351.
25. - currents in MES-SA cells. Am J Physiol 270:C1029-C1036.
26. Maeno E, Ishizaki Y, Kanaseki T, Hazama A, Okada Y. 2000. Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc Natl Acad Sci USA 97:9487-9492.
27. - channels in multi-drug resistant MCF7 cells. Biochem Biophys Res Commun 334:1266-1278.
28. Marks PA, Richon VM, Rifkind RA. 1000. Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 92:1210-1216.
29. - channel. J Membr Biol 157:63-69.
30. Mukai M, Kanzaki A, Chen ZS, Miyashita H, Sumizawa T, Furukawa T, Haraguchi M, Takebayashi Y, Takamatsu H, Akiyama S. 2002. Enhanced nucleotide excision repair in cisplatin resistant human KB carcinoma cells. Oncol Rep 9:839-844.
31. Murakami T, Shibuya I, Ise T, Chen ZS, Akiyama S, Nakagawa M, Izumi H, Nakamura T, Matsuo K, Yamada Y, Kohno K. 2001. Elevated expression of vacuolar proton pump genes and cellular PH in cisplatin resistance. Int J Cancer 93:869-874.
32. Narlikar GJ, Fan HY, Kingston RE. 2002. Cooperation between complexes that regulate chromatin structure and transcription. Cell 108:475-487.
33. Nilius B, Eggermont J, Voets T, Buyse G, Manolopoulos V, Droogmans G. 1997. Properties of volume-regulated anion channels in mammalian cells. Prog Biophys Mol Biol 68:69-119.
34. - channel: Fresh start to the molecular identity and volume sensor. Am J Physiol 273:C755-C789.
35. Okada Y, Maeno E, Shimizu T, Dezaki K, Wang J, Morishima S. 2001. Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD). J Physiol 532:3-16.
36. Okada Y, Shimizu T, Maeno E, Tanabe S, Wang X, Takahashi N. 2006. Volume-sensitive chloride channels involved in apoptotic volume decrease and cell death. J Membrane Biol 209:21-29.
37. Paulmichl M, Li Y, Wickman K, Ackerman M, Peralta E, Clapham D. 1992. New mammalian chloride channel identified by expression cloning. Nature 356:238-241.
38. Sardini A, Amey JS, Weylandt KH, Nobles M, Valverde MA, Higgins CF. 2003. Cell volume regulation and swelling-activated chloride channels. Biochem Biophys Acta 1618:153-162.
39. - channel. Proc Natl Acad Sci USA 101:6770-6773.
40. Stobrawa SM, Breiderhoff T, Takamori S, Engel D, Schweizer M, Zdebik AA, Bösl MR, Ruether K, Jahn H, Draguhn A, Jahn R, Jentsch TJ. 2001. Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus. Neuron 29:185-196.
41. Strange K, Emma F, Jackson PS. 1996. Cellular and molecular physiology of volume-sensitive anion channels. Am J Physiol 270:C711-C730.
42. Tominaga M, Tominaga T, Miwa A, Okada Y. 1995. Volume-sensitive chloride channel activity does not depend on endogenous P-glycoprotein. J Biol Chem 270:27887-27893.
43. Valverde MA, Diaz M, Sepulveda FV, Gill DR, Hyde SC, Higgins CF. 1992. Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein. Nature 355:830-833.
44. Valverde MA, Bond TD, Hardy SP, Taylor JC, Higgins CF, Altamirano J, Alvarez-Leefmans FJ. 1996. The multidrug resistance P-glycoprotein modulates cell regulatory volume decrease. EMBO J 15:4460-4468.
45. Cln in Xenopus oocytes differs from the endogenous volume-sensitive chloride current. J Physiol 495:441-447.
46. Wang D, Lippard SJ. 2005. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4:307-320.
47. Weidle UH, Grossmann A. 2000. Inhibition of histone deacetylases: A new strategy to target epigenetic modifications for anticancer treatment. Anticancer Res 20:1471-1485.
48. Wernyj RP, Morin PJ. 2004. Molecular mechanisms of platinum resistance: Still searching for the Achilles' heel. Drug Resist Updat 7:227-232.